Financhill
Back

NewGenIvf Group Quote, Financials, Valuation and Earnings

NewGenIvf Group Price Quote

$0.32
-0.06 (-15.72%)
(Updated: December 13, 2024 at 5:55 PM ET)

NewGenIvf Group Key Stats

Sell
32
NewGenIvf Group (NIVF) is a Sell

Day range:
$0.30 - $0.39
52-week range:
$0.30 - $3.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
10M
Avg. volume:
4.8M
1-year change:
0%
Market cap:
$3.9M
Revenue:
$5.1M
EPS:
$0.01

How Much Does NewGenIvf Group Make?

Is NewGenIvf Group Growing As A Company?

Data Unavailable

NewGenIvf Group Stock Price Performance

  • Did NewGenIvf Group Stock Go Up Last Month?
    NewGenIvf Group share price went down by -43.88% last month
  • Did NIVF's Share Price Rise Over The Last Year?
    NIVF share price rose by 0% over the past 1 year

What Is NewGenIvf Group 52-Week High & Low?

NewGenIvf Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NewGenIvf Group?

  • How Much Debt Does NewGenIvf Group Have?
    Total long term debt quarterly is $0
  • How Much Cash Does NewGenIvf Group Have?
    Cash and short term investments quarterly total is $54.1K
  • What Is NewGenIvf Group’s Book Value Per Share?
    Book value per share is 0.00

Is NewGenIvf Group Cash Flow Positive?

  • What Is NIVF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.8M
  • What Is NewGenIvf Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.9M
  • What Is NewGenIvf Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$69.8K

NewGenIvf Group Return On Invested Capital

Data Unavailable

NewGenIvf Group Earnings Date & Stock Price

NewGenIvf Group Competitors

  • Who Are NewGenIvf Group's Competitors?
    Below is a list of companies who compete with NewGenIvf Group or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Bangkok Dusit Medical Services PCL (BDUUF)
    • Bumrungrad Hospital PCL (BUGDF)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)

NewGenIvf Group Dividend Yield

NewGenIvf Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many NIVF shares are owned by institutional investors?
    1.3M NIVF shares are owned by institutional investors
  • How many NIVF shares are owned by insiders?
    0 NIVF shares are owned by insiders